Bharat Immunologicals & Biologicals Corporation Limited announced earnings results for the full year ended March 31, 2020. For the full year, the company announced total revenue was INR 680.202 million compared to INR 878.704 million a year ago. Net loss was INR 102.113 million compared to INR 57.931 million a year ago. Basic loss per share was INR 2.36 compared to INR 1.57 a year ago.